COVID Vaccine Update

COVID vaccine is now available for all patients age 6 months and older. Learn more here.

Pfizer Booster Qualifications

 If you completed a primary series of any approved vaccine for emergency use to prevent COVID-19, you may qualify for a Pfizer booster. 

  • The original Pfizer-BioNTech COVID-19 vaccine is a monovalent vaccine that is authorized as a single booster dose for individuals aged 5-11 years of age, at least five months after completing a primary series of an mRNA vaccine. 
  • An updated (bivalent) Pfizer booster is now available as a single booster dose for individuals 12 years of age or older, administered at least 2 months after either: 
    • Completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine, or
    • Receipt of the most recent booster dose with any authorized monovalent COVID-19 vaccine. 

Immunocompromised Patients

Certain immunocompromised patients have different vaccine recommendations. Please refer to the CDC’s website for moderately to severely immunocompromised patients for specific guidelines: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html   

Updated 9/12/22